UFP Technologies stock gained 1.94 percent on October 2

Published on 10/04/2026 at 18:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UFP Technologies stock stood at USD 300.70 on October 2, 2026, after a 1.94 percent daily increase. Q2 revenue reached USD 173.96 million against USD 159.38 million consensus.

UFPT, US9026731029, Illustration mit AI erstellt.

UFP Technologies stock (ISIN US9026731029) was last at USD 300.70 on Nasdaq on October 2, 2026, up 1.94 percent from USD 294.99. The move followed a second-quarter performance in which MarketBeat reported adjusted EPS of USD 2.92 against a USD 2.31 consensus estimate and revenue of USD 173.96 million against USD 159.38 million expected.

Q2 revenue beats consensus

The revenue gap was USD 14.58 million, equal to 9.1 percent above the consensus estimate. Adjusted EPS exceeded the estimate by USD 0.61, while the company also posted GAAP diluted EPS of USD 2.68 for Q2 2026, according to MarketBeat.

The operating picture also carries a year-over-year comparison. Q2 sales rose 15.1 percent from USD 151.2 million in Q2 2025, while net income increased 21.4 percent to USD 20.9 million, according to MarketMinute.

Analysts see further upside

MarketScreener lists an Outperform consensus from four analysts and an average price target of USD 355.00. That target is 18.1 percent above the October 2 price of USD 300.70, creating a clear gap between the latest quote and the published analyst average.

The growth strategy gained an additional transaction milestone on September 7, 2026, when UFP Technologies completed its acquisition of Creative Imprints, Inc., according to MarketScreener. The deal adds another medical-device platform to a business already focused on engineered components, sterile packaging and single-use products.

Stock stays below yearly high

At USD 300.70, the stock stood 11.2 percent below its 52-week high of USD 338.71 and well above the 52-week low of USD 173.86 on October 2, 2026. The session volume was 117,147 shares, and the company had a market capitalization of USD 2.3 billion.

For investors, the central trade-off is visible in the numbers: UFP Technologies is delivering double-digit sales growth and earnings beats, while the share price remains below its yearly peak. The next market assessment will depend on whether the acquisition pipeline and medical-device demand can sustain the Q2 growth rate.